Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06319352Not ApplicableCompleted

Evaluation of Quality-of-Life Improvements Using UroShield Device

Role: collaborator

NCT03090373Not ApplicableUnknown

The Effect of Surface Acoustic Waves on the Prevention of Colonization in Longterm Indwelling Urinary Caatheters

Role: collaborator

NCT02801630Not ApplicableUnknown

An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia

Role: collaborator

NCT00781248Phase 2Completed

Safety and Efficacy Study of the NG Shield, a Device Intended to Reduce Pain and Discomfort Level Related to Nasogasstric Tube Usage

Role: lead

NCT00446732Phase 2Unknown

The Use of the UroShield Device in Patients With Indwelling Urinary Catheters

Role: lead

NCT00737425Phase 4Unknown

Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery

Role: collaborator

NCT00702286Unknown

Evaluation of Surface Acoustics Ultrasound Device for the Treatment of Patients With Percutaneous Nephrostomy Catheters

Role: collaborator

All 7 trials loaded